Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
What we have learned from the Myriad trials.
Hendrix SB, Wilcock GK. Hendrix SB, et al. Among authors: wilcock gk. J Nutr Health Aging. 2009 Apr;13(4):362-4. doi: 10.1007/s12603-009-0044-7. J Nutr Health Aging. 2009. PMID: 19300881 No abstract available.
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.
Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, Sperling R, Wilcock GK, Fox N, Scheltens P, Touchon J, Hendrix S, Andrieu S, Aisen P; EU/US/CTAD Task Force Members. Vellas B, et al. Among authors: wilcock gk. Alzheimers Dement. 2013 Jul;9(4):438-44. doi: 10.1016/j.jalz.2013.03.007. Alzheimers Dement. 2013. PMID: 23809364
Biomarkers for Alzheimer's disease therapeutic trials.
Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; Oxford Task Force Group. Hampel H, et al. Among authors: wilcock g. Prog Neurobiol. 2011 Dec;95(4):579-93. doi: 10.1016/j.pneurobio.2010.11.005. Epub 2010 Dec 2. Prog Neurobiol. 2011. PMID: 21130138 Review.
Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.
Aisen P, Touchon J, Andrieu S, Boada M, Doody R, Nosheny RL, Langbaum JB, Schneider L, Hendrix S, Wilcock G, Molinuevo JL, Ritchie C, Ousset PJ, Cummings J, Sperling R, DeKosky ST, Lovestone S, Hampel H, Petersen R, Legrand V, Egan M, Randolph C, Salloway S, Weiner M, Vellas B. Aisen P, et al. Among authors: wilcock g. J Prev Alzheimers Dis. 2016;3(2):68-74. doi: 10.14283/jpad.2016.97. J Prev Alzheimers Dis. 2016. PMID: 29210442
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M, Dallob A, Chappell D, Snyder K, Flynn M, Simon A, Modur V, Potter WZ, Wilcock G, Savage MJ, Smith AD. Seeburger JL, et al. Among authors: wilcock g. J Alzheimers Dis. 2015;44(2):525-39. doi: 10.3233/JAD-141725. J Alzheimers Dis. 2015. PMID: 25391385
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.
Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, Hasselbalch SG, Hausner L, Heuser I, Jessen F, Jones RW, Kurz A, Lawlor B, Lleo A, Martinez-Lage P, Mecocci P, Mehrabian S, Monsch A, Nobili F, Nordberg A, Rikkert MO, Orgogozo JM, Pasquier F, Peters O, Salmon E, Sánchez-Castellano C, Santana I, Sarazin M, Traykov L, Tsolaki M, Visser PJ, Wallin ÅK, Wilcock G, Wilkinson D, Wolf H, Yener G, Zekry D, Frisoni GB. Bocchetta M, et al. Among authors: wilcock g. Alzheimers Dement. 2015 Feb;11(2):195-206.e1. doi: 10.1016/j.jalz.2014.06.006. Epub 2014 Aug 20. Alzheimers Dement. 2015. PMID: 25150733
Bapineuzumab in Alzheimer's disease: where now?
Wilcock GK. Wilcock GK. Lancet Neurol. 2010 Feb;9(2):134-6. doi: 10.1016/S1474-4422(09)70359-X. Lancet Neurol. 2010. PMID: 20129159 No abstract available.
The increasing burden of Alzheimer disease.
Sadik K, Wilcock G. Sadik K, et al. Among authors: wilcock g. Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17 Suppl 3:S75-9. doi: 10.1097/00002093-200307003-00003. Alzheimer Dis Assoc Disord. 2003. PMID: 14512820 Review.
Resting functional connectivity reveals residual functional activity in Alzheimer's disease.
Zamboni G, Wilcock GK, Douaud G, Drazich E, McCulloch E, Filippini N, Tracey I, Brooks JC, Smith SM, Jenkinson M, Mackay CE. Zamboni G, et al. Among authors: wilcock gk. Biol Psychiatry. 2013 Sep 1;74(5):375-83. doi: 10.1016/j.biopsych.2013.04.015. Epub 2013 May 28. Biol Psychiatry. 2013. PMID: 23726515
Galantamine in Alzheimer's disease.
Razay G, Wilcock GK. Razay G, et al. Among authors: wilcock gk. Expert Rev Neurother. 2008 Jan;8(1):9-17. doi: 10.1586/14737175.8.1.9. Expert Rev Neurother. 2008. PMID: 18088197 Review.
190 results
Jump to page